<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101247089</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32436</journal-id>
<journal-id journal-id-type="nlm-ta">Eur J Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur J Med Genet</journal-id>
<journal-title-group>
<journal-title>European journal of medical genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1769-7212</issn>
<issn pub-type="epub">1878-0849</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27633569</article-id>
<article-id pub-id-type="pmc">5064849</article-id>
<article-id pub-id-type="doi">10.1016/j.ejmg.2016.09.006</article-id>
<article-id pub-id-type="manuscript">NIHMS818186</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>17p13.3 microduplication including <italic>CRK</italic> leads to overgrowth and elevated growth factors: A case report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Henry</surname>
<given-names>Rohan K.</given-names>
</name>
<degrees>M.D., M.S.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Astbury</surname>
<given-names>Caroline</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stratakis</surname>
<given-names>Constantine A.</given-names>
</name>
<degrees>M.D., MedSci</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hickey</surname>
<given-names>Scott E.</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Division of Endocrinology, Department of Pediatrics, Nationwide Children's Hospital/The Ohio State University College of Medicine, Columbus, Ohio 43205, USA</aff>
<aff id="A2"><label>2</label>Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital</aff>
<aff id="A3"><label>3</label>Department of Pathology, The Ohio State University College of Medicine</aff>
<aff id="A4"><label>4</label>Developmental Endocrinology and Genetics, National Institute of Child Health and Human Development(NICHD), National Institute of Health (NIH), Bethesda, Maryland 20892, USA</aff>
<aff id="A5"><label>5</label>Division of Molecular &amp; Human Genetics, Department of Pediatrics, Nationwide Children's Hospital/The Ohio State University College of Medicine</aff>
<author-notes>
<corresp id="FN1">Address correspondence to: Rohan K. Henry, MD, MS, Nationwide Children's Hospital, Division of Endocrinology, 700 Children's Drive, Columbus, OH 43205, Telephone: 614-722-4425; FAX: 614-722-4440, <email>rohan.henry@nationwidechildrens.org</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p><bold>Disclosure Statement:</bold> The authors declare that there is no conflict of interests regarding the publication of this article.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2017</year>
</pub-date>
<volume>59</volume>
<issue>10</issue>
<fpage>512</fpage>
<lpage>516</lpage>
<!--elocation-id from pubmed: 10.1016/j.ejmg.2016.09.006-->
<abstract>
<p id="P1">17p13.3 microduplications classified as class I duplications involving <italic>YWHAE</italic> but not <italic>PAFAH1B1</italic> (formerly <italic>LIS1</italic>) and class II duplications which extend to involve <italic>PAFAH1B1</italic>, are associated with diverse phenotypes including intellectual disability and structural brain malformations. We report a girl with an approximately 1.58 Mb apparently terminal gain of 17p13.3, which contains more than 20 genes including the <italic>YWHAE</italic> and <italic>CRK</italic> genes (OMIM: 164762). She had increased growth factors accompanied by pathologic tall stature. In addition to these, she developed central precocious puberty at 7 years old. In individuals with class I 17p13.3 microduplications including CRK, we recommend biochemical evaluation of the growth hormone axis. Providers caring for these patients should be aware of their possible risk for the development of central precocious puberty.</p>
</abstract>
<kwd-group>
<kwd>17p13.3 microduplications</kwd>
<kwd><italic>CRK</italic> gene</kwd>
<kwd>growth factors</kwd>
<kwd>central precocious puberty</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>